They may feel that recent PRs (except for the DGM one) had no positive impact and in many cases we saw a slide after the release. Is it possible they are stacking it up for the Q2 release and hope to have a major impact?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.